Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-019-02183-5.pdf
Reference77 articles.
1. Malmstrom PU, Sylvester RJ, Crawford DE, Friedrich M, Krege S, Rintala E et al (2009) An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette–Guerin for non-muscle-invasive bladder cancer. Eur Urol 56(2):247–256
2. Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Da Silva CF, Powell PH et al (2010) Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette–Guerin, and bacillus Calmette–Guerin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 57(5):766–773
3. Zuiverloon TC, Zwarthoff EC (2016) Predicting response to intravesical bacillus Calmette–Guerin immunotherapy: are we moving forward? Eur Urol 69(2):201–202
4. Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M (2003) Intravesical bacillus Calmette–Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. J Urol 169(6):2110–2112
5. Herr HW, Milan TN, Dalbagni G (2015) BCG-refractory vs BCG-relapsing non-muscle-invasive bladder cancer: a prospective cohort outcomes study. Urol Oncol 33(3):108 e1–108 e4
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration;International Journal of Molecular Sciences;2024-05-01
2. Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette–Guérin Therapy in Non-Muscle-Invasive Bladder Cancer;Cancers;2024-04-26
3. Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study;Annals of Surgical Oncology;2024-04-03
4. Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG);Expert Opinion on Pharmacotherapy;2024-02-11
5. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures;Aging;2024-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3